Deals In Depth: May 2018
Executive Summary
In a $969 million deal, Genentech is investing in Lodo Therapeutics’ soil microbiome research to discover natural products. After several offers, Shire agreed a $79 billion takeover by Takeda, which moves into the top 10 pharma companies. Biopharma financing was slightly down while device financing increased, with a large proportion coming from FOPOs.